Spasticity After Spinal Cord Injury

Spinal Cord Injuries Clinical Trial

Official title:

Spasticity After Spinal Cord Injury

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04393922
• Other study ID #: STU00212201
• Status: Recruiting
• Phase: N/A
• Start date: May 13, 2020
• Est. completion date: May 18, 2024

Study information

• Verified date: June 2022
• Source: Shirley Ryan AbilityLab
• Contact: Sina Sangari, PhD
• Phone: 312.238.1365
• Email: ssangari[@]rsralab.org
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Very often, people who have a SCI have difficulty doing things with their arms or hands as a result of muscle stiffness , or spasticity. Spastacity can cause problems performing even the simplest of everyday tasks. This research will help us understand how the body recovers and changes neurologically after SCI.

Description:

After spinal cord injury (SCI), damage to descending motor pathways has been associated with the development of spasticity (Frigon and Rossignol, 2006; Trompetto et al., 2014). Self-reported questionnaires and clinical exams indicate that individuals with incomplete SCI, who showed residual descending connectivity, have a high prevalence of spasticity compared to individuals with complete SCI (Little et al., 1989; Holtz et al., 2017). In agreement, our recent electrophysiological and spinal cord imaging data in humans with a diagnosis of a clinically motor complete SCI showed the presence of descending motor pathway connectivity in individuals with spasticity compared to those without spasticity (Sangari et al., 2019). However, which descending motor pathways influence spasticity following SCI, and to what extent, remains poorly understood. This proposal has two main goals: 1) to examine the contribution of cortico- and reticulo-spinal pathways to spasticity in upper and lower limb muscles, and 2) to develop strategies to promote functional recovery of upper and lower limb spastic muscles in humans with chronic incomplete SCI. The aims below will test two main hypotheses. In Aim 1, we will use transcranial magnetic stimulation and startle acoustic stimuli to examine the contribution of the cortico- and reticulo-spinal pathway to upper and/or lower limb muscles electromyographic activity. Spinal cord atrophy and morphological characterization of cortico- and reticulo-spinal pathways will be assessed with high-resolution magnetic resonance imaging. Physiological and neuroimaging outcomes will be associated with clinical assessment of spasticity. In Aim 2, we propose to enhance cortico- and reticulo-spinal contribution to upper and/or lower limb function in spastic muscles by using a novel intervention combining startle acoustic stimuli with motor training. This research will provide new knowledge about the contribution of descending motor pathways to the control of spasticity in upper and lower limb muscles following incomplete cervical SCI (Aim1) and might lead to the development of a novel rehabilitation intervention to improve upper and lower limb motor function recovery by enhancing residual descending control over spinal networks (Aim 2).

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 120
• Est. completion date: May 18, 2024
• Est. primary completion date: June 18, 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 75 Years

Eligibility

Inclusion criteria for individuals with SCI

• Chronic SCI (=1 year of injury)
• Incomplete spinal cord injury at T12 or above
• Males and Females
• Ages 18-75 years Inclusion criteria for non-spastic individuals with SCI -MAS scores of 0 and 1 Inclusion criteria for spastic individuals with SCI
• MAS scores of 2, 3 and 4
• The ability to perform a voluntary flexion and extension of the elbow and/or knee or ankle
• The ability to reach and grasp an object Inclusion criteria for health controls
• Males and females
• Ages 18-75 years
• Right-handed
• Able to perform elbow and/or knee or ankle flexion and extension

Exclusion Criteria for individuals with SCI and healthy controls:

• Uncontrolled medical problems including pulmonary, cardiovascular, or orthopedic disease
• Any debilitating disease prior to the SCI that caused exercise intolerance
• Premorbid, ongoing major depression or psychosis, altered cognitive status
• History of head injury or stroke
• Pacemaker
• Metal plate in skull
• History of seizures
• Receiving drugs acting primarily on the central nervous system, which lower the seizure threshold such as antipsychotic drugs (chlorpromazine, clozapine) or tricyclic antidepressants
• Pregnant females
• Ongoing cord compression or a syrinx in the spinal cord or who suffer from a spinal cord disease such as spinal stenosis, spina bifida, or herniated cervical disk

Related Conditions & MeSH terms

• Muscle Spasticity
• Spinal Cord Injuries
• Wounds and Injuries

Intervention

Behavioral:
• Acoustic stimuli (Startle)
A startle stimulus (120 dB, 500 Hz, 50 ms) will be delivered through headphones

Locations

Country	Name	City	State
United States	Shirley Ryan AbilityLab	Chicago	Illinois

Sponsors (1)

Lead Sponsor	Collaborator
Shirley Ryan AbilityLab

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	MEP recruitment curves	Ten stimuli (0.2 Hz) will be delivered at each intensity to plot the mean peak-to-peak amplitude of the MEP from the non-rectified response against the TMS intensity in each subject (MEP recruitment curve).	3-4 hours
Primary	Ipsilateral MEPs (iMEPs)	Ten stimuli will be delivered during head straight and ten stimuli will be delivered during lateral head rotation, randomly alternated (0.2 Hz).	3-4 hours
Primary	StartReact	Here, participants will be asked to observe a light-emitting diode (LED) located in front of their head. When the LED will illuminate, individuals will be asked to move their arm or leg. In some trials, the LED will be presented with either a quiet acoustic stimulus (80 dB, 500 Hz, 50 ms) or a startling acoustic stimulus (SAS, 120 dB, 500 Hz, 50 ms) delivered through a headphone.	3-4 hours
Primary	Participant reported spasticity	Spasticity questionnaire	3-4 hours
Primary	Modified Ashworth Scale (MAS)	This scale measures resistance encountered during manual passive muscle stretching using a six-point ordinal scale.	3-4 hours
Primary	Portable Spasticity Assessment Device (PSAD)'	The PSAD combine biomechanical and electrophysiological measurements for an objective quantification of active and passive component of muscle stiffness	3-4 hours
Primary	Pendulum Test	As part of the physical exam, we will use the pendulum test to measure muscle tone at the knee by using gravity to provoke muscle stretch reflexes during passive swinging of the lower limb.	3-4 hours
Primary	10-meter walk test	10-meter walk test will be used to assess walking speed	3-4 hours
Primary	Graded and Redefined Assessment of Strength, Sensibility and Prehension (GRASSP).	This exam measures clinical impairment that incorporates three domains vital to upper-limb function: sensation, strength, and prehension.	3-4 hours
Primary	Toronto Rehabilitation Institute-Hand Function Test (TRI-HFT)	This exam measures gross motor function frequently used to manipulate objects that participants may encounter in their daily lives.	3-4 hours